Daily Vitamin K in Patients on Warfarin With Unstable INRs
NCT00287313 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 15
Last updated 2010-01-12
Summary
The purpose of this study is to determine if daily Vitamin K supplementation stabilizes INRs in patients taking warfarin with a history of frequent dose changes or variable INRs.
Conditions
- Anticoagulants
- Warfarin
Interventions
- DRUG
-
Vitamin K
Sponsors & Collaborators
-
University of North Carolina, Chapel Hill
lead OTHER
Principal Investigators
-
Stephan Moll, M.D. · University of North Carolina, Chapel Hill
Study Design
- Allocation
- NON_RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2005-10-31
- Primary Completion
- 2006-05-31
- Completion
- 2006-05-31
Countries
- United States
Study Locations
More Related Trials
-
Reinitiation of Anticoagulation After Temporary Withdrawal of Vitamin K Antagonist
NCT01348074 ·Status: COMPLETED ·Phase: PHASE2
-
Excessive Warfarin Anticoagulation - Causes and Consequences
NCT02761941 ·Status: UNKNOWN
-
A Study to Explore the Pharmacodynamic Changes When Transitioning From Rivaroxaban to Warfarin in Healthy Volunteers
NCT01400646 ·Status: COMPLETED ·Phase: PHASE1
-
Benefit/Risk in Real Life of New Oral Anticoagulants and Vitamin K Antagonists in Patients Aged 80 Years and Over
NCT02286414 ·Status: COMPLETED
-
Clinical Validation of a New Algorithm for Computerized Dosing of Vitamin K Antagonist Therapy
NCT01392040 ·Status: COMPLETED
-
Factors Associated to the Instability of the INR (International Normalized Ratio ) in the Prevention of Thromboembolism AVK (Anti Vitamin K) in Atrial Fibrillation in the Elderly: Instead of Comorbidities
NCT02841475 ·Status: COMPLETED
-
Anticoagulant Clinics and Vitamin K Antagonists
NCT00966290 ·Status: COMPLETED ·Phase: PHASE4
-
Switching Study From Warfarin to Rivaroxaban
NCT01507051 ·Status: COMPLETED ·Phase: PHASE1
-
INR at Home Measurement by the LabPad® Point-of-care in Patients on Vitamin K Antagonist Drugs (VKA)
NCT04117048 ·Status: COMPLETED ·Phase: NA
-
Prospective Evaluation of an Extended Interval of INR Follow-up in a VA Anticoagulation Service
NCT02392104 ·Status: COMPLETED ·Phase: NA
-
Safety Study of Vitamin K2 During Anticoagulation in Human Volunteers
NCT00512928 ·Status: COMPLETED ·Phase: NA
-
Clarification of Optimal Anticoagulation Through Genetics
NCT00839657 ·Status: COMPLETED ·Phase: PHASE3
-
The Effect of Medication Timing on Anticoagulation Stability in Users of Warfarin: The "INRange" RCT
NCT02376803 ·Status: COMPLETED ·Phase: PHASE4
-
Prothrombin Times Outside the Therapeutic Range in Otherwise Stable Patients
NCT00814177 ·Status: COMPLETED ·Phase: PHASE2
-
Benefit/Risk in Real Life of New Oral Anticoagulants and Vitamin K Antagonists in Patients Aged 75 Years and Over Suffering From Non Valvular Atrial Fibrillation (nv AF)
NCT02906527 ·Status: UNKNOWN
-
Balancing of Patients Treated by Vitamin K Antagonists (VKAS) in General Medicine
NCT03914053 ·Status: COMPLETED
-
Residual Vein Thrombosis Establishes the Optimal Duration of Oral Anticoagulants
NCT00438230 ·Status: COMPLETED ·Phase: PHASE4
-
Improving Anticoagulant Therapy Through Warfarin Metabolite Profiling
NCT01964794 ·Status: COMPLETED
-
Fixed Versus Variable Dosing of 4-factor Prothrombin Complex Concentrate for Emergent Warfarin Reversal
NCT03064035 ·Status: COMPLETED ·Phase: PHASE4
-
Prolongation of the Interval Between Monitoring of Warfarin in Stable Patients
NCT00356759 ·Status: COMPLETED ·Phase: PHASE2
-
Does Thinning the Blood During Surgery Prevent Blood Clots Following Total Knee Replacement Surgery
NCT00253851 ·Status: COMPLETED ·Phase: PHASE4
-
Anticoagulation Therapy in Non-device-related Intra-cardiac Thrombus
NCT05825573 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Duloxetine - Warfarin Pharmacodynamic Study
NCT00533026 ·Status: COMPLETED ·Phase: PHASE1
-
Genotype-Guided Warfarin Therapy Trial
NCT00904293 ·Status: COMPLETED ·Phase: NA
-
Use of Phytonadione to Reduce International Normalized Ratio (INR) Variability in Patients on Long-term Warfarin Therapy
NCT01474460 ·Status: COMPLETED ·Phase: NA